Rehabilitation

Global Bionic Devices Research Report 2024: Market to Surpass $10.25+ Billion by 2030, Driven by Transformative Impact on Quality of Life in Retaining Mobility and Independence - ResearchAndMarkets.com

Retrieved on: 
Monday, April 29, 2024

The demand for bionic devices has surged in recent times because of their transformative effect on the quality of existence.

Key Points: 
  • The demand for bionic devices has surged in recent times because of their transformative effect on the quality of existence.
  • North America dominated the global bionic devices market in 2023 and is anticipated to lead the market throughout the forecast period.
  • The electronic bionic devices captured a significant share of the global bionic devices market in 2023.
  • It is predicted that the ambulatory surgical centers will capture nearly a quarter share of the total bionic devices market.

Federal Home Loan Bank of Dallas Commits Nearly $100 Million to Four Key Affordable Housing Initiatives

Retrieved on: 
Tuesday, April 30, 2024

The Federal Home Loan Bank of Dallas (FHLB Dallas) has made available $99.4 million in grants this year through its Affordable Housing Program (AHP) and AHP homeownership programs.

Key Points: 
  • The Federal Home Loan Bank of Dallas (FHLB Dallas) has made available $99.4 million in grants this year through its Affordable Housing Program (AHP) and AHP homeownership programs.
  • View the $100 Million in AHP video to see the impact of the programs.
  • “Our nation has a critical shortage of affordable housing options,” said FHLB Dallas President and CEO Sanjay Bhasin.
  • “The HELP program sponsored by FHLB Dallas has been tremendous in helping Red River Bank create affordable housing in all of our markets,” said Senior Vice President Jannease Seastrunk, community relations & CRA officer at Red River Bank.

The Bancorp, Inc. Reports First Quarter Financial Results

Retrieved on: 
Thursday, April 25, 2024

The Bancorp, Inc. (“The Bancorp” or “the Company” or “we” or “our”) (NASDAQ: TBBK), a financial holding company, today reported financial results for the first quarter of 2024.

Key Points: 
  • The Bancorp, Inc. (“The Bancorp” or “the Company” or “we” or “our”) (NASDAQ: TBBK), a financial holding company, today reported financial results for the first quarter of 2024.
  • Net interest income increased 10% to $94.4 million for the quarter ended March 31, 2024, compared to $85.8 million for the quarter ended March 31, 2023.
  • Net interest margin amounted to 5.15% for the quarter ended March 31, 2024, compared to 4.67% for the quarter ended March 31, 2023, and 5.26% for the quarter ended December 31, 2023.
  • Those changes reflected an increase of 2% quarter over linked quarter and an increase of 2% year over year.

Sheppard Mullin Lands Healthcare Partner Stephanie Marcantonio in New York

Retrieved on: 
Wednesday, April 24, 2024

Sheppard, Mullin, Richter & Hampton LLP is pleased to announce that Healthcare partner Stephanie Marcantonio has joined the firm’s New York office.

Key Points: 
  • Sheppard, Mullin, Richter & Hampton LLP is pleased to announce that Healthcare partner Stephanie Marcantonio has joined the firm’s New York office.
  • Marcantonio joins from Crowell & Moring LLP where she was a partner and a member of its corporate steering committee.
  • In Marcantonio’s healthcare practice, she represents post-acute healthcare providers and other healthcare entities in connection with divestitures, mergers, affiliations and joint ventures, many of which also include significant real estate components.
  • “Investing in our transactional capabilities, particularly within the healthcare sector, remains a key priority for the firm,” said Luca Salvi, chair of Sheppard Mullin.

SAIL Fusion Announces FDA Clearance of its BowTie™ Sacroiliac Fusion System

Retrieved on: 
Tuesday, April 23, 2024

SAIL Fusion, a medical device company focused on advancing the surgical treatment of sacroiliac joint dysfunction through solutions built upon proven AO principles, today announced that it has received FDA clearance for its novel BowTie Sacroiliac Fusion System.

Key Points: 
  • SAIL Fusion, a medical device company focused on advancing the surgical treatment of sacroiliac joint dysfunction through solutions built upon proven AO principles, today announced that it has received FDA clearance for its novel BowTie Sacroiliac Fusion System.
  • The system will be launched to a select group of initial surgeons in preparation for a greater expansion in the coming months.
  • “There hasn’t been meaningful differentiation in the SI fusion market for many years,” remarked David Jansen, the President & CEO of SAIL.
  • Our approach challenges the prevailing trend of lateral fixation that is more appropriate for stabilization rather than true joint fusion.

Lifepoint Rehabilitation Acquires Inpatient Rehabilitation Facility in San Antonio, Texas from Everest Rehabilitation Hospitals

Retrieved on: 
Tuesday, April 16, 2024

Lifepoint Rehabilitation, a business unit of Lifepoint Health®, today announced that it has acquired an inpatient rehabilitation facility in San Antonio, Texas from Everest Rehabilitation Hospitals, a multispecialty rehabilitation hospital company.

Key Points: 
  • Lifepoint Rehabilitation, a business unit of Lifepoint Health®, today announced that it has acquired an inpatient rehabilitation facility in San Antonio, Texas from Everest Rehabilitation Hospitals, a multispecialty rehabilitation hospital company.
  • “We are so pleased to welcome the San Antonio team to Lifepoint,” said Russ Bailey, president of Lifepoint Rehabilitation.
  • “We are pleased to complete this transaction with Lifepoint Rehabilitation,” said Jay Quintana, chief executive officer of Everest Rehabilitation Hospitals.
  • “We know that Lifepoint shares our patient-centered vision for rehabilitation care and that their attention to continued investment in people and technology will promote excellent outcomes for patients in and beyond San Antonio.”
    This transaction is the third between Lifepoint Health and Everest Rehabilitation Hospitals, following Lifepoint’s February 2023 acquisition of four inpatient rehabilitation facilities located in Longview, Texas; Temple, Texas; Rogers, Arkansas; and Cincinnati, Ohio and Lifepoint’s August 2023 acquisition of an inpatient rehabilitation facility in El Paso, Texas from Everest Rehabilitation Hospitals.

Rio Tinto releases first quarter production results

Retrieved on: 
Tuesday, April 16, 2024

In the Pilbara, we produced 77.9 million tonnes (Rio Tinto share 66.1 million tonnes) in the first quarter, 2% lower than the corresponding period of 2023.

Key Points: 
  • In the Pilbara, we produced 77.9 million tonnes (Rio Tinto share 66.1 million tonnes) in the first quarter, 2% lower than the corresponding period of 2023.
  • Shipments of 78.0 million tonnes (Rio Tinto share 66.1 million tonnes) were 5% lower than the first quarter of 2023.
  • Kennecott mined copper production was 7% higher than the first quarter of 2023 but 32% lower than the previous quarter, primarily, due to unplanned conveyor downtime.
  • All currency figures in this report are US dollars, and comments refer to Rio Tinto’s share of production, unless otherwise stated.

Digital Therapeutics Market Global and Regional Analysis and Forecast, 2023-2033: Utilization of AI and ML with Digital Therapeutics Growing in Prominence - ResearchAndMarkets.com

Retrieved on: 
Friday, April 12, 2024

Multiple Benefits Provided by Digital Therapeutics over Traditional Treatment: The adoption of digital therapeutics is surging due to their personalized, technology-driven approach to managing various conditions.

Key Points: 
  • Multiple Benefits Provided by Digital Therapeutics over Traditional Treatment: The adoption of digital therapeutics is surging due to their personalized, technology-driven approach to managing various conditions.
  • Continuous Technological Advancements Driving the Adoption of Digital Therapeutics: Digital therapeutics is rising, fueled by technology and widespread smartphones.
  • Increasing Demand for Cost-Effective Solutions Creating a Demand for Digital Therapeutics: As healthcare costs are increasing, digital therapeutics rise as a cost-effective alternative.
  • Rising Fundings and Investment in Digital Therapeutics: The digital therapeutics market is experiencing an investment boom, propelling its growth and paving the way for healthcare advancements.

E-Textile Market Size to Grow USD 5238.3 Million by 2029 at a CAGR of 8% | Valuates Reports

Retrieved on: 
Friday, April 26, 2024

The Global E-Textile Market size is expected to reach USD 5238.3 Million by 2029, growing at a CAGR of 8.0% from 2023 to 2029.

Key Points: 
  • The Global E-Textile Market size is expected to reach USD 5238.3 Million by 2029, growing at a CAGR of 8.0% from 2023 to 2029.
  • The e-textile industry is growing due in large part to civil applications, which cover a variety of sectors and daily usage.
  • Furthermore, the military, healthcare, and sports and fitness sectors all have strong demand, which propels market expansion in North America.
  • In addition, the region's market development is further stimulated by favorable government programs and financing assistance for technical improvements.

E-Textile Market Size to Grow USD 5238.3 Million by 2029 at a CAGR of 8% | Valuates Reports

Retrieved on: 
Friday, April 26, 2024

The Global E-Textile Market size is expected to reach USD 5238.3 Million by 2029, growing at a CAGR of 8.0% from 2023 to 2029.

Key Points: 
  • The Global E-Textile Market size is expected to reach USD 5238.3 Million by 2029, growing at a CAGR of 8.0% from 2023 to 2029.
  • The e-textile industry is growing due in large part to civil applications, which cover a variety of sectors and daily usage.
  • Furthermore, the military, healthcare, and sports and fitness sectors all have strong demand, which propels market expansion in North America.
  • In addition, the region's market development is further stimulated by favorable government programs and financing assistance for technical improvements.